Laddar...
Atacicept: targeting B cells in multiple sclerosis
Multiple sclerosis (MS) has traditionally been considered to be a T-cell-mediated disease. However, there is an increasing body of evidence for the involvement of B cells and autoantibodies in the pathology of this disease, providing a rationale for treatments directed against B cells. In this paper...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3002656/ https://ncbi.nlm.nih.gov/pubmed/21179612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285610371146 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|